Doctor profile · Federal record

Dr. Tiffany Brazeal, M.D.

Dermatology Physician (CMS: Dermatology) · Oklahoma City, OK

  • NPI 1942239199
  • Accepts Medicare
  • MIPS 85.7 / 100 · 2023
  • 20 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
9720 Broadway Ext
Oklahoma City, OK 731146315
(405) 280-7546
fax (405) 772-8674
Mailing address
Po Box 268986
Oklahoma City, OK 731268986

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
October 20, 2014
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Oklahoma #27705

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1942239199. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,979
Distinct HCPCS
10
Medicare allowed
$277,599
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,810 312 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 1,045 761 $84
17000 Destruction of precancer skin growth, 1 growth 574 437 $47
11102 Biopsy of related skin growth, first growth 429 338 $84
99214 Established patient office or other outpatient visit, 30-39 minutes 378 303 $120
17110 Destruction of skin growth, 1-14 growths 303 266 $102
11103 Biopsy of related skin growth, each additional growth 203 104 $47
99203 New patient office or other outpatient visit, 30-44 minutes 52 52 $106
17004 Destruction of precancer skin growth, 15 or more growths 38 33 $157
99204 New patient office or other outpatient visit, 45-59 minutes 28 28 $158

In context: peer comparison

Among 17 peers in this city , average services per provider: 233. This provider delivers 21× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,827
Transactions
141
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
E.R. Squibb & Sons, L.L.C. 20 $368.76
Janssen Biotech, Inc. 10 $297.66
Lilly USA, LLC 16 $274.83
GENZYME CORPORATION 14 $268.31
Novartis Pharmaceuticals Corporation 17 $243.05
PFIZER INC. 13 $216.40
ABBVIE INC. 15 $205.66
Amgen Inc. 7 $189.64
SUN PHARMACEUTICAL INDUSTRIES INC. 8 $176.09
LEO Pharma Inc. 8 $157.09
Regeneron Healthcare Solutions, Inc. 3 $92.14
Incyte Corporation 4 $69.53
Organogenesis Inc. 2 $54.31
Boehringer Ingelheim Pharmaceuticals, Inc. 2 $41.90
Dermavant Sciences, Inc. 2 $36.60

By nature of payment

Food and Beverage
$2,720
Education
$107

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
674
Patients
336
Total drug cost
$363,860
Drug Type Claims Patients Total cost
Clobetasol Propionate Generic 133 79 $9,424
Dupixent Pen (Dupilumab) Brand 69 0 $257,290
Fluocinonide Generic 67 46 $3,798
Doxycycline Hyclate Generic 54 24 $4,134
Fluorouracil Generic 54 48 $5,403
Ketoconazole Generic 44 26 $1,562
Spironolactone Generic 38 13 $1,104
Triamcinolone Acetonide Generic 36 23 $343
Minoxidil Generic 35 11 $597
Mupirocin Generic 33 26 $329

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Tiffany Brazeal's medical specialty?
Dr. Tiffany Brazeal practices Dermatology Physician in Oklahoma City, OK.
Where does Dr. Tiffany Brazeal practice?
Dr. Tiffany Brazeal practices at 9720 Broadway Ext, Oklahoma City, OK 731146315. Office phone: 4052807546.
What is Dr. Tiffany Brazeal's NPI?
Dr. Tiffany Brazeal's National Provider Identifier (NPI) is 1942239199, issued by NPPES.
Does Dr. Tiffany Brazeal accept Medicare assignment?
Yes. Dr. Tiffany Brazeal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tiffany Brazeal commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.